NAIAD Drug Design

Artificial Intelligence, Bioinformatics, Biotechnology, Pharmaceutical
Founded in 1/1/18
Santo André, Sao Paulo, Brazil
For Profit

About NAIAD Drug Design

NAIAD is an early-stage drug discovery startup focused on the development of new drugs targeting G-Protein coupled receptors GPCRs. NAIAD's platform integrates molecular modelling, bioinformatics, chemoinformatics and AI in order to perform in silico screnings with a throughput of billions of molecules. The company currently have four ongoing projects in its pipeline.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: None USD
  • Last Funding: None (Seed)
  • Funding Status: Seed

Technology Stack

NAIAD Drug Design actively uses None products in their tech stack.

Market Presence

Industries: Artificial Intelligence, Bioinformatics, Biotechnology, Pharmaceutical

Headquarters: Santo André, Sao Paulo, Brazil